Abstract
The antimicrobial drug, trimethoprim, was evaluated for genotoxicity in human peripheral blood lymphocyte cultures set-up from two healthy donors. Sister-chromatid exchanges (SCE) and micronuclei (MN) were scored as genetic endpoints. The treatment was done using different trimethoprim concentrations ranging from 1 to 100 μg/ml. From our results, we can conclude that this drug is able to induce both cytotoxic and moderate genotoxic effects, as revealed by the increases seen in SCE and MN frequencies in cultures from the two donors and, at least, at one of the concentrations tested. Copyright (C) 1999 Elsevier Science B.V.
| Original language | English |
|---|---|
| Pages (from-to) | 157-162 |
| Journal | Mutation Research - Genetic Toxicology and Environmental Mutagenesis |
| Volume | 440 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 6 Apr 1999 |
Keywords
- Diaminopyrimidine
- Human lymphocyte
- Micronucleus
- Sister chromatid exchange (SCE)
- Trimethoprim
Fingerprint Dive into the research topics of 'Genotoxic evaluation of the antimicrobial drug, trimethoprim, in cultured human lymphocytes'. Together they form a unique fingerprint.
Cite this
Abou-Eisha, A., Creus, A., & Marcos, R. (1999). Genotoxic evaluation of the antimicrobial drug, trimethoprim, in cultured human lymphocytes. Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 440(2), 157-162. https://doi.org/10.1016/S1383-5718(99)00022-4